Ethical Concerns about Psilocybin Intellectual Property
ACS Pharmacology & Translational Science January 1, 2021 Konstantin Gerber, Inti García Flores, Angela Christina Ruiz et al. 54 citations
Since a 1957 Life Magazine article, chemical compounds from Psilocybe mushrooms have been the subject of many patent attempts, including recent ones for treating depression. The Mazatec indigenous communities, who have used these traditional medicines for millennia, are not included in any of these patents, despite international treaties that recognize indigenous rights to their intangible cultural heritage.